← All stocks

Co-Diagnostics, Inc.

CODX Net buying
CIK 0001692415 #5352 in the set updated 22 Sep 2026
Bought (120 mo)
$11.82M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$6.16M
$0.00 on a plan · $3.70M straight out of an exercise
Sold at will
$2.46M
12 of 20 sales
Net
+$5.66M
+$9.36M against sales at will

By person

12 insiders · 30 transactions
0.1×

Dwight Egan holds only 0.1 times base salary in stock. $52.97K of shares against $400.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dwight Egan last reported holding, valued at $1.90, the price Common Stock was last bought or sold at on the open market here, on 20 Mar 2023.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Satterfield Brent
Former Chief Science Officer
$11.81M (5)
+$11.81M
2,275,000
$4.32M
+0.2%
BENSON REED L
General Counsel
$1.86M (4) scheduled
−$1.86M
20,962
$39.81K
−45.4%
Egan Dwight H
Chief Executive Officer
$1.84M (4) scheduled
−$1.84M
27,893
$52.97K
SERBIN RICHARD S
Director
$1.19M (5)
−$1.19M
10,751
$20.42K
Durenard Eugene
Director
$1.14M (5)
−$1.14M
10,668
$20.26K
NELSON JAMES B
Director
$126.63K (2)
−$126.63K
10,668
$20.26K
Brown Brian Lee
Chief Financial Officer
$5.70K (1)
+$5.70K
22,379
$42.50K
Reagents, LLC entity
Former 10% Owner
1,746,796
$3.32M
−10.6%
MURPHY TED
Director
224,167
$425.69K
+1,693%
Murphy Edward L.
Director
11,084
$21.05K
Abbott Richard David
President
3,417
$6.49K
America 2030 Capital, LLC entity
10% owner
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 16.9 over the window, from 3,602,465 to 60,892,582 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Brown Brian Lee
20 Mar 2023
Chief Financial Officer
Buy
3,000
$1.90
$5.70K
Durenard Eugene
8 Sep 2021
Director
Sell
2,000
$10.46
$20.91K
BENSON REED L
19 May 2021
General Counsel
Sold after exercise
1
$8.53
$8.53
BENSON REED L
19 May 2021
General Counsel
Sold after exercise
97,413
$8.52
$830.39K
BENSON REED L
19 May 2021
General Counsel
Sold after exercise
10,920
$8.54
$93.23K
Egan Dwight H
15 Jan 2021
Chief Executive Officer
Sold after exercise
38,046
$11.00
$418.51K
SERBIN RICHARD S
14 Jan 2021
Director
Sell
10,000
$10.29
$102.90K
NELSON JAMES B
13 Jan 2021
Director
Sell
600
$10.14
$6.08K
NELSON JAMES B
13 Jan 2021
Director
Sell
11,900
$10.13
$120.55K
Durenard Eugene
13 Jan 2021
Director
Sell
10,500
$10.09
$105.95K
SERBIN RICHARD S
14 Dec 2020
Director
Sell
17,000
$10.10
$171.70K
Durenard Eugene
10 Dec 2020
Director
Sell
10,000
$10.15
$101.50K
BENSON REED L
25 Nov 2020
CFO and Secretary
Sold after exercise
89,524
$10.50
$940.00K
Egan Dwight H
24 Nov 2020
Chief Executive Officer
Sold after exercise
44,764
$10.51
$470.47K
Egan Dwight H
23 Nov 2020
Chief Executive Officer
Sold after exercise
71,569
$10.44
$747.18K
Egan Dwight H
20 Nov 2020
Chief Executive Officer
Sold after exercise
18,017
$11.09
$199.81K
SERBIN RICHARD S
28 May 2020
Director
Exercised, kept
25,000
$3.96
$99.00K
SERBIN RICHARD S
28 May 2020
Director
Sell
7,500
$18.00
$135.00K
SERBIN RICHARD S
28 May 2020
Director
Sell
17,500
$18.03
$315.53K
Durenard Eugene
26 May 2020
Director
Sell
25,000
$18.26
$456.50K
Durenard Eugene
20 May 2020
Director
Exercised, kept
25,000
$3.96
$99.00K
Durenard Eugene
20 May 2020
Director
Exercised, kept
25,000
$0.71
$17.75K
Durenard Eugene
20 May 2020
Director
Sell
25,000
$18.40
$460.00K
SERBIN RICHARD S
19 May 2020
Director
Exercised, kept
25,000
$0.71
$17.75K
SERBIN RICHARD S
19 May 2020
Director
Sell
25,000
$18.50
$462.50K
Satterfield Brent
11 May 2018
Chief Science Officer
Buy
1,305
$1.82
$2.38K
Satterfield Brent
3 May 2018
Chief Science Officer
Buy
500
$1.91
$955.00
Satterfield Brent
23 Apr 2018
Chief Science Officer
Buy
500
$2.02
$1.01K
Satterfield Brent
16 Apr 2018
Chief Science Officer
Buy
500
$1.94
$970.00
Satterfield Brent
9 Apr 2018
Chief Science Officer
Buy
2,400
$4,920.00
$11.81M

What was left out

Form 4 filings counted 141
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 8
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 6,764,321
Sales filed before the plan box existed 12
History held since 18 Dec 2017